 Home > Medical News > Latest Medical News > The next generation of BRAF inhibitors into the brain!

The next generation of BRAF inhibitors into the brain!

 Last Update: 2022-01-12
 Source: Internet
 Author: User

Tags

colon cancer images

fulvic acid cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

ArticleMedicine Guanlan

On November 30th, ABM Therapeutics announced that its self-developed BRAF inhibitor ABM-1310 clinical trial application was approved by the National Medical Products Administration (NMPA), allowing the company to target patients with advanced solid tumors with BRAF mutations Carry out a phase 1 clinical trial

ABM-1310 is an innovative small molecule drug independently developed by Bichen Pharmaceutical.

ABM-1310, developed by Bichen Pharmaceutical, has shown its ideal advantages in blood-brain barrier penetration in pre-clinical studies

Currently, the Phase 1 clinical trial of ABM-1310 is proceeding smoothly in the United States, and the initial data has shown good safety and positive information

Reference materials:

[1] The BRAF inhibitor ABM-1310 IND of Bichen Pharmaceutical was approved by China National Medical Products Administration.

[2] ABM Therapeutics will appear at the 2020 American Society for Cancer Research Annual Meeting.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.